Robert Menendez actually said...

Under the current structure, PBMs make more money when a drug's list price increases, while patients bear the financial burden.

To have the opportunity to think about these issues with Rudy is going to be an interesting opportunity.

it is also just fascinating, because I know the area that he represents, northern Indiana.

Absolutely. And I don't have any more time, but that was because the chair got my name wrong, so, I yield back my negative time. Thanks so m...